Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.432 USD | +2.86% | -6.86% | -38.37% |
10/05 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
21/03 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NORTHWEST BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | +2.86% | -6.86% | -38.37% | -33.74% | +56.52% | 529M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- NWBO Stock
- Charts Northwest Biotherapeutics, Inc.
- Comparison Chart